Barclays PLC Nevro Corp Call Options Transaction History

Barclays PLC

5 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q4 2022 Feb 13, 2023	BUY	$36.43 - $49.4 $852,462 - $1.16 Million	23,400 New	23,400 $927,000
Q4 2020 Feb 11, 2021	BUY	$138.17 - $184.34 $1.23 Million - $1.64 Million	8,900 Added 25.36%	44,000 $7.62 Million
Q4 2018 Feb 14, 2019	BUY	$35.43 - $56.29 $478,305 - $759,915	13,500 Added 62.5%	35,100 $1.37 Million
Q2 2018 Aug 14, 2018	BUY	$72.38 - $92.5 $1.11 Million - $1.42 Million	15,400 Added 248.39%	21,600 $1.73 Million
Q1 2018 May 15, 2018	BUY	$69.46 - $88.57 $430,651 - $549,134	6,200 New	6,200 $537,000

151

39.3M

67.9K

1.59M

Ticker NVRO
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 35,387,800
Market Cap $133M
Description
Nevro Corp., a medical device company, provides products for patients suffering from chronic pain in the United States and internationally. The company develops and commercializes the Senza spinal cord stimulation system, an evidence-based neuromodulation platform for the treatment of chronic pain, as well as Senza II and Senza Omnia systems. It...

Get notified when there are updates to the investment portfolio of Barclays PLC, based on Form 13F filings with the SEC.

Stay updated on Barclays PLC with notifications on news.